RUBIUS THERAPEUTICS, INC.

Profile

Company Names

RUBIUS THERAPEUTICS, INC.

Addresses

325 VASSAR STREET, SUITE 1A, CAMBRIDGE, MA 02139

Phone Numbers

617-679-9600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$216,200,065.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-02-23 
$101,200,005.00 
$101,200,005.00 
$0.00 
Equity 
1
2017-06-07 
$115,000,060.00 
$120,000,064.00 
$5,000,004.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NOUBAR 
B. 
AFEYAN 
DIRECTOR
HELICOS BIOSCIENCES CORP   |  LS22, INC.   |  CIBO TECHNOLOGIES, INC.   |  RUBIUS THERAPEUTICS, INC.
CHRISTOPHER 
L. 
CARPENTER 
EXECUTIVE OFFICER
RUBIUS THERAPEUTICS, INC.
FRANCIS 
 
CUSS 
DIRECTOR
RUBIUS THERAPEUTICS, INC.   |  GLYMPSE BIO, INC.
DAVID 
 
EPSTEIN 
DIRECTOR
AERIE PHARMACEUTICALS INC   |  2100 FREEDOM, INC.   |  METASTAT, INC.   |  BACK9BEVERAGES LLC   |  RUBIUS THERAPEUTICS, INC.   |  PALMIA CORP
PETER 
BARTON 
HUTT 
DIRECTOR
BIND BIOSCIENCES INC   |  SELECTA BIOSCIENCES INC   |  BLEND BIOSCIENCES, INC.   |  Q HOLDINGS, INC.   |  BLEND THERAPEUTICS, INC.   |  BIND BIOSCIENCES, INC   |  LIVING PROOF INC   |  SERES HEALTH, INC.   |  FLEX PHARMA, INC.   |  PRONUTRIA BIOSCIENCES, INC.   |  SUNEVA MEDICAL INC.   |  AXCELLA HEALTH INC.   |  WHOLE BIOME INC.   |  RUBIUS THERAPEUTICS, INC.   |  CEREHEALTH CORP   |  ATELERIX LIFE SCIENCES INC.   |  COLABS INT-L, CORP.
ROBERT 
S. 
LANGER 
DIRECTOR
LIVING PROOF INC   |  BLEND BIOSCIENCES, INC.   |  BLEND THERAPEUTICS, INC.   |  MICROCHIPS BIOTECH, INC.   |  TARVEDA THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  LYNDRA, INC.   |  RUBIUS THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.
HARVEY 
F. 
LODISH 
DIRECTOR
RUBIUS THERAPEUTICS, INC.
TORBEN 
STRAIGHT 
NISSEN 
EXECUTIVE OFFICER, DIRECTOR
RUBIUS THERAPEUTICS, INC.
ANDREW 
 
OH 
EXECUTIVE OFFICER
RUBIUS THERAPEUTICS, INC.   |  SYROS PHARMACEUTICALS, INC.
ROGER 
 
POMERANTZ 
DIRECTOR
SERES HEALTH, INC.   |  X-VAX TECHNOLOGY, INC.   |  RUBIUS THERAPEUTICS, INC.   |  COLLPLANT BIOTECHNOLOGIES LTD   |  VIRACTA THERAPEUTICS, INC.   |  VIRACTA SUBSIDIARY, INC.   |  VERIMMUNE, INC.
JOANNE 
 
PROTANO 
EXECUTIVE OFFICER
RUBIUS THERAPEUTICS, INC.
MICHAEL 
 
ROSENBLATT 
DIRECTOR
RPROJECTS, INC.   |  SEAMLESS TOY COMPANY, INC.   |  RUBIUS THERAPEUTICS, INC.   |  AXCELLA HEALTH INC.
CATHERINE 
 
SOHN 
DIRECTOR
NEURALSTEM, INC.   |  RUBIUS THERAPEUTICS, INC.   |  LANDEC CORP \CA\   |  BIOECLIPSE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-03-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
2017-06-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#